A Phase III Double-Blinded, Randomized, Multicenter, Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX Made With an Alternative Manufacturing Process (AMP).
Phase of Trial: Phase III
Latest Information Update: 17 Apr 2017
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Pharmacodynamics
- Sponsors Merck & Co
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.